"10"^^ . "tolerability; efficacy; second generation antipsychotics; mood stabilizers; bipolar disorder"@en . . . "Farmakoterapie bipol\u00E1rn\u00ED afektivn\u00ED poruchy"@cs . "RIV/00179906:_____/12:10124074" . . . "The Pharmacotherapy Of Bipolar Disorder"@en . "2" . "[296773FBE2BC]" . "I" . . . "Sd\u011Blen\u00ED se zam\u011B\u0159uje na d\u016Fkazy podlo\u017Een\u00E9 postaven\u00ED farmak v l\u00E9\u010Db\u011B m\u00E1nie, deprese a udr\u017Eovac\u00ED terapie bipol\u00E1rn\u00ED afektivn\u00ED poruchy (BAP) a sledov\u00E1n\u00ED bezpe\u010Dnosti p\u0159i dlouhodob\u00E9 l\u00E9\u010Db\u011B. Z\u00E1kladem l\u00E9\u010Dby bipol\u00E1rn\u00ED poruchy je pod\u00E1v\u00E1n\u00ED thymoprofylaktika (stabiliz\u00E1toru n\u00E1lady) v ka\u017Ed\u00E9 f\u00E1zi onemocn\u011Bn\u00ED. V posledn\u00ED dob\u011B p\u0159ib\u00FDvaj\u00ED d\u016Fkazy o \u00FA\u010Dinnosti antipsychotik druh\u00E9 generace (A2G) v jednotliv\u00FDch f\u00E1z\u00EDch BAP. V klinick\u00E9 praxi jsou v l\u00E9\u010Db\u011B st\u00E1le \u010Dast\u011Bji pou\u017E\u00EDv\u00E1na. D\u016Fvodem je vedle jejich \u00FA\u010Dinnosti tak\u00E9 rychlej\u0161\u00ED n\u00E1stup \u00FA\u010Dinku a odli\u0161n\u00E9 spektrum vedlej\u0161\u00EDch ne\u017E\u00E1douc\u00EDch \u00FA\u010Dink\u016F ve srovn\u00E1n\u00ED s %22klasick\u00FDmi%22 thymoprofylaktiky lithiem, valpro\u00E1tem a karbamazepinem. K p\u0159evaze A2G v\u00FDznamn\u011B p\u0159isp\u011Blo roz\u0161\u00ED\u0159en\u00ED diagn\u00F3zy bipol\u00E1rn\u00ED poruchy o jednotky charakterizovan\u00E9 r\u016Fznou sm\u011Bs\u00ED afektivn\u00EDch p\u0159\u00EDznak\u016F." . "Farmakoterapie bipol\u00E1rn\u00ED afektivn\u00ED poruchy" . "2"^^ . "Masopust, Ji\u0159\u00ED" . . "1211-7579" . "2"^^ . . "FR - Francouzsk\u00E1 republika" . . "Farmakoterapie bipol\u00E1rn\u00ED afektivn\u00ED poruchy"@cs . . . "Sd\u011Blen\u00ED se zam\u011B\u0159uje na d\u016Fkazy podlo\u017Een\u00E9 postaven\u00ED farmak v l\u00E9\u010Db\u011B m\u00E1nie, deprese a udr\u017Eovac\u00ED terapie bipol\u00E1rn\u00ED afektivn\u00ED poruchy (BAP) a sledov\u00E1n\u00ED bezpe\u010Dnosti p\u0159i dlouhodob\u00E9 l\u00E9\u010Db\u011B. Z\u00E1kladem l\u00E9\u010Dby bipol\u00E1rn\u00ED poruchy je pod\u00E1v\u00E1n\u00ED thymoprofylaktika (stabiliz\u00E1toru n\u00E1lady) v ka\u017Ed\u00E9 f\u00E1zi onemocn\u011Bn\u00ED. V posledn\u00ED dob\u011B p\u0159ib\u00FDvaj\u00ED d\u016Fkazy o \u00FA\u010Dinnosti antipsychotik druh\u00E9 generace (A2G) v jednotliv\u00FDch f\u00E1z\u00EDch BAP. V klinick\u00E9 praxi jsou v l\u00E9\u010Db\u011B st\u00E1le \u010Dast\u011Bji pou\u017E\u00EDv\u00E1na. D\u016Fvodem je vedle jejich \u00FA\u010Dinnosti tak\u00E9 rychlej\u0161\u00ED n\u00E1stup \u00FA\u010Dinku a odli\u0161n\u00E9 spektrum vedlej\u0161\u00EDch ne\u017E\u00E1douc\u00EDch \u00FA\u010Dink\u016F ve srovn\u00E1n\u00ED s %22klasick\u00FDmi%22 thymoprofylaktiky lithiem, valpro\u00E1tem a karbamazepinem. K p\u0159evaze A2G v\u00FDznamn\u011B p\u0159isp\u011Blo roz\u0161\u00ED\u0159en\u00ED diagn\u00F3zy bipol\u00E1rn\u00ED poruchy o jednotky charakterizovan\u00E9 r\u016Fznou sm\u011Bs\u00ED afektivn\u00EDch p\u0159\u00EDznak\u016F."@cs . "http://www.tigis.cz/images/stories/psychiatrie/2012/02/07_masopust_psych_2-12.pdf" . . "Farmakoterapie bipol\u00E1rn\u00ED afektivn\u00ED poruchy" . "This article summarizes the current knowledge on the efficacy, tolerability, and safety of the drugs used in the treatment of mania, depression, and bipolar disorder in the maintenance phase. Mood stabilizer is the cornerstone of the treatment of bipolar disorder in all phases. A growing body of evidence on the beneficial effect of second generation antipsychotics (A2G) in various stages has recently been accumulated. A2G have been increasingly used in clinical practice. Apart from their efficacy, a more rapid onset of action and different range of adverse effects in comparison with the classical mood stabilizers, such as lithium, valproate and carbamazepine, are the reason for this development. The broadening of the diagnosis of bipolar spectrum with states characterized with admixtures of affective symptoms has been an argument supporting the superiority of the A2G."@en . . . "Psychiatrie" . "RIV/00179906:_____/12:10124074!RIV13-MZ0-00179906" . . "16" . . . "The Pharmacotherapy Of Bipolar Disorder"@en . . "136178" . "Homolkov\u00E1, Barbora" .